Population and Public Health
Dubai’s GluCare has released its first set of findings, taken over 90 days since launch. Report shows that diabetic patients achieved an average HbA1c reduction of 1.7% in just three months.
Interested researchers must submit a letter of intent describing their research and how they will use Fitbit’s products and services in it.
Its partnership with the Kingdom’s Ministry of Health marks the debut of the AVNeo in the region, making Saudi Arabia the first country from the Council to offer the advanced solution.
The social media giant will begin notifying its users when they become eligible for a COVID-19 vaccine in their state.
GE Research has received a grant from the NIH to develop sensors that can be embedded into mobile devices to detect COVID-19 particles on their surfaces.
The digital therapeutic is designed to treat children ages 8 to 12 with ADHD, but the two studies announced this week will focus on an adult population.
Funding will be used to gain in-human data for startup’s OxiFlow brain haemorrhage solution.
System which identifies patients at risk of fatal heart attack obtains CE mark.
Hayat-Vax is a joint collaboration between Sinopharm CNBG and Abu Dhabi’s G42. Meanwhile, the country’s COVID-19 contact tracing app will now also function as a national vaccine registry.
Private bookings for a COVID-19 vaccine start from AED 1,300 (approx. $354).